New grad roles at Apellis Pharmaceuticals
Apellis Pharmaceuticals develops and commercializes medicines that target C3 in the complement system. Its therapies address serious diseases in ophthalmology, nephrology, and hematology, including geographic atrophy, C3 glomerulopathy, primary IC-MPGN, and PNH.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 501–1,000 employees
- Open roles
- 9
No current roles
Check back soon.
Get new Apellis Pharmaceuticals new grad roles by email
Free account. Get new Apellis Pharmaceuticals new grad roles by email or push the minute they post.
